An evaluation framework for non-medical prescribing researchAndrew R. Hale A F , Danielle A. Stowasser B , Ian D. Coombes C D , Julie Stokes E and Lisa Nissen D
A Medication Services Queensland, Citilink Building 2, Lobby 4 Level 1, 153 Campbell Street, Bowen Hills, QLD 4006, Australia.
B National Prescribing Service, Level 7/418a Elizabeth Street, Surry Hills, NSW 2010, Australia.
C Royal Brisbane Women’s Hospital, Herston, Brisbane, QLD 4006, Australia.
D Pharmacy Australia Centre of Excellence, University of Queensland, Level 4, 20 Cornwall Street, Woolloongabba, QLD 4102, Australia.
E Safe Medication Management Unit, Medication Services Queensland, Citilink Building 2, Lobby 4 Level 1, 153 Campbell Street, Bowen Hills, QLD 4006, Australia.
F Corresponding author. Email: email@example.com
Submitted: 6 December 2010 Accepted: 12 October 2011 Published: 25 May 2012
Without robust and credible evidence for the benefits in health outcomes of non-medical prescribing, widespread implementation will be challenging. Our aim is to develop a consistent evaluation framework that could be applied to non-medical prescribing research. An informal collaboration was initiated in 2008 by a group of pharmacists from Australia and New Zealand to assist in information sharing, pilot design, methodologies and evaluation for pharmacist prescribing. Different pilots used different models, methodologies and evaluation. It was agreed that the development of a consistent evaluation framework to be applied to future research on non-medical prescribing was required. The framework would help to align the outcomes of different research pilots and enable the comparison of endpoints to determine the effectiveness of a non-medical prescribing intervention.
This article presents the results of a workshop held at The University of Queensland in January 2009. Participants were asked to consider how to evaluate the effectiveness of different models of pharmacist prescribing.
What is known about the topic? Little is known about the effectiveness and safety of non-medical prescribing services due to a lack of robust evidence.
What does this paper add? This paper adds a methodology for clinicians and healthcare managers to be able to evaluate any new service of non-medical prescribing, either in the pilot phase or once introduced as a new model of care.
What are the implications for practitioners? The implication for practitioners is the ability to prove to healthcare providers that non-medical prescribing services are at least as effective as usual care, so informing whether a change should be introduced in the way healthcare is delivered to patients.
References National Health Workforce Taskforce (NHWT). Health workforce in Australia and factors for current shortages. Australia’s Health Workforce Online; 2009. Available at: http://ahwo.gov.au/documents/NHWT/The%20health%20workforce%20in%20Australia%20and%20factors%20influencing%20current%20shortages.pdf [verified 28 November 2009].
 Australian Diagnostic Imaging Association (ADIA). Productivity commission, health workforce submission. Australian Government Productivity Commission Online; 2005. Available at: http://www.pc.gov.au/_data/assets/pdf_file/0012/10263/sub056.pdf
 Australian Institute of Health and Welfare (AIHW). Medical labour force 2005. Canberra: AIHW; 2008.
 Brooks P, Lapsley H, Butt D. Medical workforce issues in Australia: ‘tomorrow’s doctors – too few, too far’. Med J Aust 2003; 4 206–8.
 Department of Health and Ageing (DHA). National medicines policy. Canberra: DHA; 2000.
 Shojania K, Duncan B, McDonald K. Safe but sound: patient safety meets evidence-based medicine. JAMA 2002; 288 508–13.
| Safe but sound: patient safety meets evidence-based medicine.CrossRef |
 Wilson R, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD. The Quality in Australian Health Care study. Med J Aust 1995; 163 458–71.
| 1:STN:280:DyaK28%2FosV2qsQ%3D%3D&md5=e676eca63292f5ebf3d048b7d8e42abaCAS |
 Coombes I, Stowasser DA, Reid C, Mitchell CA. Impact of a standard medication chart in prescribing errors: a before and after audit. Qual Saf Health Care 2009; 18 478–85.
| Impact of a standard medication chart in prescribing errors: a before and after audit.CrossRef | 1:STN:280:DC%2BD1MjpvVWrsA%3D%3D&md5=0671ad5d79c9e25023264b1913a4deebCAS |
 Hughes C. Medication errors in hospital: what can be done? Med J Aust 2008; 188 267–8.
 Hughes C. Medication errors in hospital: what can be done. Med J Aust 2008; 188 266–7.
 Roughead E, Barratt J, Gilbert A. Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf 2004; 13 83–7.
| Medication-related problems commonly occurring in an Australian community setting.CrossRef | 1:STN:280:DC%2BD2c7gslOiug%3D%3D&md5=b80210db2fd31685f4358f7f8952207dCAS |
 Miller G, Britt H, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust 2006; 184 321–4.
 Kowanko I, de Crespigny C, Murray H, Groenkjaer M, Emden C. Better medication management for Aboriginal people with mental health disorders: a survey of providers. Aust J Rural Health 2004; 12 253–7.
| Better medication management for Aboriginal people with mental health disorders: a survey of providers.CrossRef |
 Gordon L, et al Fuel, beds, meals and meds: out-of-pocket expenses for patients with cancer in rural Queensland. Cancer Forum 2009; 33
 National Health and Hospitals Reform Commission (NHHRC). A healthier future for all Australians – final report. NHHRC; 2009.
 National Health Workforce Taskforce (NHWT). Health workforce in Australia and factors for current shortages. Canberra: NHWT; 2009.
 Department of Health (DoH). Review of prescribing, supply and administration of medicines. A report on the supply and administration of medicines under group protocols. London: DoH; 1998.
 Crown J. Review of prescribing, supply and administration of medicines. Final report. London: Department of Health; 1999.
 Tonna AP, Stewart D, West B, McCaig D. Pharmacist prescribing in the UK – a literature review of current practice and research. J Clin Pharm Ther 2007; 32 545–56.
| Pharmacist prescribing in the UK – a literature review of current practice and research.CrossRef | 1:STN:280:DC%2BD2snosl2jsw%3D%3D&md5=66ebc103126ef3436865bcfd213baef6CAS |
 Courtenay M, Carey N. Nurse independent prescribing and nurse supplementary prescribing practice: national survey. J Adv Nurs 2008; 61 291–9.
| Nurse independent prescribing and nurse supplementary prescribing practice: national survey.CrossRef |
 Yuksel N, Eberhart G, Bungard TJ. Prescribing by pharmacists in Alberta. Am J Health Syst Pharm 2008; 65 2126–32.
| Prescribing by pharmacists in Alberta.CrossRef |
 Forchuk C, Kohr R. Prescriptive authority for nurses: the Canadian perspective. Perspect Psychiatr Care 2009; 45 3–8.
| Prescriptive authority for nurses: the Canadian perspective.CrossRef |
 Gardner JS, et al Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study. J Am Pharm Assoc 2008; 48 212–221.
 Manchester A. Nurses gain right to prescribe. Wellington: 1998.
 Cooper RJ, Anderson C, Avery T, Bissell P, Guillaume L, Hutchinson A, et al Nurse and pharmacist supplementary prescribing in the UK – a thematic review of the literature. Health Policy 2008; 85 277–92.
| Nurse and pharmacist supplementary prescribing in the UK – a thematic review of the literature.CrossRef |
 Van Der Weyden M. Doctor displacement: a political agenda or a health care imperative? Med J Aust 2008; 189 608–9.
 Ford P. Medication prescribing – not a task for non-medical health practitioners. Journal of Pharmacy Practice and Research 2008; 38 256
 Winstanley L. A vision for pharmacist prescribing. Pharmaceutical Journal 2009; 282 276–7.
 The Pharmacy Guild of Australia (PGA). The roadmap. The strategic direction for community pharmacy. PGA; 2010.
 National Health Performance Committee (NHPC). National health performance framework report. Brisbane: NHPC; 2001.